{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Predictive Variables for Mortality in Endovascular Thrombectomy: A Secondary Analysis of the DEFUSE 3 Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 1,
        "evidence": "This cohort analysis included 92 EVT-treated patients from the DEFUSE 3 trial, selected based on specific inclusion criteria."
      },
      "Intervention": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Objective": {
        "score": 1,
        "evidence": "This secondary analysis identifies predictive variables for mortality in EVT-treated patients."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was mortality within 90 days."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Of the 92 patients (mean age 69 years; 50% male), 15.2% met the primary outcome."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Mortality rates were 3.9% in low-risk, 13.0% in moderate-risk, and 52.9% in high-risk categories (P<0.001)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 8,
    "max_score": 25
  },
  "model": "gpt-4o"
}